Frasergen
Latest round
- Series B
Last raised
- Nov 2017
Total raised
- $7.5M
Investors
- 1
About Frasergen
Established in 2012 and based in Wuhan, China, Frasergen is a biotechnology company. It provides services including third and second generation sequencing, 3D genomics, bioinformatics software development and genome databases construction, etc.
Who invested in Frasergen
1 investor across 1 round
See all investors in Frasergen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 12, 2017
Amount
$7.5M
Investors
Questions about Frasergen
Who invested in Frasergen?
Frasergen has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Frasergen raised?
Frasergen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Frasergen last raise money?
Frasergen's most recent round on record is a Series B, in Nov 2017.
What does Frasergen do?
Established in 2012 and based in Wuhan, China, Frasergen is a biotechnology company.
Where is Frasergen headquartered?
Frasergen is headquartered in Wuhan, China.
Which VCs invest in companies like Frasergen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Frasergen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Frasergen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.